more frequent side effects
hypersensitivity reaction
comprehensive list of adverse effects
study
twice-daily abacavir
combination with lamivudine
efavirenz
patients
receiving once-daily abacavir
higher incidence of severe drug hypersensitivity reactions
severe diarrhea than patients on the twice-daily regimen
side effects
patients with abacavir hypersensitivity
nausea
vomiting
diarrhea
fever
lethargy
rash
fatal hypersensitivity reactions
abacavir
such reactions
multi-organ failure
anaphylaxis
first weeks of abacavir therapy
median onset
days
abacavir hypersensitivity reactions
time during therapy
patients with the human leukocyte antigen subtype b *
hla-b *
allele
higher risk of abacavir hypersensitivity reactions
such reactions
patients without the hla-b
allele
abacavir hypersensitivity
patients in clinical trials with abacavir-containing products
patients
hla-b
allele
incidence
suspected abacavir hypersensitivity reactions
clinical trials
hla-b
carriers
abacavir hypersensitivity reactions
following
following key signs/symptoms
fever
rash
gastrointestinal symptoms
including nausea
vomiting
diarrhea
abdominal pain
constitutional symptoms
including
generalized malaise
fatigue
achiness
respiratory symptoms
including dyspnea
cough
pharyngitis
reactions
fever
rash
reactions
fever
rash
signs/symptoms
patients with hypersensitivity reaction
rash
nausea
vomiting
diarrhea
abdominal pain
dyspnea
cough
fever
fatigue/lethargy
malaise
headache
elevated liver function tests
myalgia
other signs/symptoms of hypersensitivity
mouth ulceration
sore throat
adult respiratory distress syndrome
respiratory failure
edema
lymphadenopathy
hypotension
conjunctivitis
anaphylaxis
paresthesia
lymphopenia
hepatitis
liver failure
myolysis
arthralgia
elevated creatine phosphokinase
elevated creatinine
renal failure
abnormal chest x-ray findings
infiltrates
death
symptoms of abacavir hypersensitivity reaction
continued therapy
abacavir
restarting abacavir after a hypersensitivity reaction
severe symptoms within hours
life-threatening hypotension
death
life-threatening reactions
hours
restarting abacavir in patients
reasons
symptoms of hypersensitivity
key symptom of hypersensitivity
abacavir
lamivudine
drug hypersensitivity-postmarketing reports
sensitization reactions
including anaphylaxis
abacavir
hypersensitivity reactions
including fever
rash
nausea
vomiting
diarrhea
abdominal pain
pharyngitis
malaise
fatigue
achiness
dyspnea
cough
lethargy
headache
myalgia
arthralgia
myolysis
edema
abnormal chest x-ray findings
localized infiltrates
paresthesia
anaphylaxis
hepatitis
liver failure
renal failure
hypotension
sore throat
adult respiratory distress syndrome
respiratory failure
death
lymphadenopathy
mucous membrane lesions
conjunctivitis
mouth ulceration
erythema multiforme
elevated liver function tests
elevated creatine phosphokinase
elevated creatinine
lymphopenia
lamivudine
frequency
anaphylactoid reactions
abacavir
lamivudine
elevated alt
elevated ast-uncommon
abnormal bilirubin-frequency
severe hepatomegaly with steatosis-postmarketing reports
hepatic steatosis
posttreatment exacerbation of hepatitis babacavir
frequency
liver function test abnormalities
elevated ggtlamivudine
transient elevations in liver enzymes
ast
alt
hepatitis-frequency
elevated bilirubin
elevated hepatic enzymes
hepatic decompensation
severe acute exacerbations of hepatitis
lactic acidosis
steatosis
including
fatal cases
use of nucleoside analogs
elevated ggt
expanded access program for abacavir
hepatic decompensation
patients
hiv
hepatitis c virus
receiving combination
antiretroviral therapy for hiv
interferon alfa
ribavirin
severe acute exacerbations of hepatitis
patients with hepatitis b after discontinuation of lamivudine
abacavir
lamivudine
nausea
diarrhea
abdominal pain/gastritis
abnormal amylase-postmarketing reports
stomatitisabacavir
nausea
vomiting
diarrhea-postmarketing reports
pancreatitis
lamivudine
nausea
vomiting
abdominal pain/cramps
diarrhea-frequency
elevated lipase-postmarketing reports
elevated serum amylase
pancreatitis
pancreatitis
expanded access program for abacavir
suspected stevens-johnson syndrome
sjs
toxic epidermal necrolysis
patients
using abacavir
combination with agents
sjs
cases of erythema multiforme
sjs
abacavir hypersensitivity
abacavir
lamivudine
rash-postmarketing reports
alopecia
erythema multiforme
stevens-johnson syndrome
urticariaabacavir
frequency
sweet
syndrome-postmarketing reports
rash without systemic symptoms
erythema multiforme
stevens-johnson syndrome
toxic epidermal necrolysis
lamivudine
rash-rare
angioedema-frequency
pruritus
urticaria-postmarketing reports
alopecia
abacavir
lamivudine
abnormal absolute neutrophils-uncommon
abnormal hemoglobin
abnormal platelets
abnormal wbc-postmarketing reports
aplastic anemia
anemia
including
pure red cell aplasia
severe anemias
therapy
lymphadenopathy
splenomegalyabacavir
frequency
anemia
neutropenia
agranulocytosislamivudine
thrombocytopenia
neutropenia
anemia-postmarketing reports
pure red cell aplasia
agranulocytosis
addition of abacavir
multi-drug regimen
neutropenia
anemia
lamivudine
abacavir
lamivudine
headache/migraine
dizziness/vertigo-postmarketing reports
peripheral neuropathy
paresthesia
seizuresabacavir
headachelamivudine
headache-postmarketing reports
paresthesia
peripheral neuropathy
emergence of lamivudine-resistant hbv
hiv
hbv-coinfected patients
using lamivudine-containing antiretroviral regimens
abacavir
lamivudine
fatigue/malaise
pyrexia-postmarketing reports
weaknessabacavir
fever
lethargy
fatiguelamivudine
fatigue
malaise
fever-frequency
drug-resistant hepatitis b virus
hbv
abacavir
lamivudine
insomnia
depression/depressed mood
abnormal dreams
anxietylamivudine
insomnia
lactic acidosis
steatosis
including
fatal cases
use of nucleoside analogs
redistribution/accumulation of body fat
antiretroviral therapy
causality
abacavir
lamivudine
abnormal alkaline phosphatase
abnormal glucose
abnormal sodium-frequency
lactic acidosis-postmarketing reports
hyperglycemia
redistribution/accumulation of body fatabacavir
anorexia-frequency
elevated blood glucose
elevated triglycerides-postmarketing reports
hyperlactatemia
lactic acidosis
lamivudine
postmarketing reports
hyperlactatemia
lactic acidosis
combination
antiretroviral therapy
frequency
redistribution/accumulation of body fat
including
central obesity
dorsocervical fat enlargement
peripheral wasting
facial wasting
breast enlargement
cushingoid appearance
metabolic abnormalities
hypertriglyceridemia
hypercholesterolemia
insulin resistance
hyperglycemia
hyperlactatemia
abacavir
lamivudine
abnormal creatine phosphokinase
cpk
postmarketing reports
muscle weakness
cpk elevation
rhabdomyolysisabacavir
frequency
elevated cpklamivudine
postmarketing reports
arthralgia
muscle disorders
rhabdomyolysis
combination
antiretroviral therapy
frequency
osteonecrosis
abacavir
postmarketing reports
myocardial infarction
mi
observational study
rate of mi in patients on combination
antiretroviral therapy
increased risk of mi with the use of abacavir within the previous months
sponsor-conducted pooled analysis of clinical trials
excess risk of mi in abacavir-treated patients
control subjects
available data from the observational cohort
clinical trials
frequency
immune reconstitution/reactivation syndrome
autoimmune disorders in the setting of immune reconstitution
graves
disease
polymyositis
guillain-barre syndrome
abacavir
lamivudine
abnormal creatinine
abacavir
lamivudine
postmarketing reports
abnormal breath sounds/wheezinglamivudine
cough
nasal symptoms
stomach pain
cough
diarrhea
fever
headache
nausea
numbness
tingling of the face
feet
hands
pain in the joints
pain in the muscles
shortness of breath
skin rash
sore throat
swelling of the feet
lower legs
unusual feeling of discomfort
illness
unusual tiredness
weakness
vomiting
blistering
peeling
loosening of the skin
bloating
burning
numbness
tingling
painful sensations
chest pain
chills
constipation
convulsions
dark urine
decreased appetite
diarrhea
difficulty with swallowing
dizziness
fast heartbeat
fast, shallow breathing
feeling of fullness
general feeling of discomfort
hives
welts
itching
indigestion
light-colored stools
loss of appetite
loss of bladder control
muscle cramping
muscle spasm
jerking of all extremities
pains in the stomach
side
abdomen
radiating
back
pale skin
puffiness
swelling of the eyelids
eyes
face
lips
tongue
red, irritated eyes
redness of the skin
red skin lesions
purple center
sleepiness
sores
ulcers
white spots on the lips
mouth
sudden loss of consciousness
tender lymph glands in the neck
armpit
groin
tightness in the chest
troubled breathing with exertion
unsteadiness or awkwardness
unusual bleeding
bruising
stomach pain
weakness in the arms
hands
legs
feet
yellow eyes
skin
abnormal dreams
burning feeling in the chest
stomach
fear or nervousness
feeling of constant movement of self
surroundings
lightheadedness
sensation of spinning
throbbing headache
stomach upset
tenderness in the stomach area
trouble sleeping
abnormal breathing sounds
blurred vision
burning
crawling
itching
numbness
prickling
pins
needles
tingling feelings
dry mouth
flushed, dry skin
fruit-like breath odor
gaining weight
neck
breast
face
waist
hair loss
increased hunger
increased thirst
increased urination
muscle weakness
sweating
swelling
inflammation of the mouth
thinning of the hair
unexplained weight loss